| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |